(Q39124241)

9 September 2017

Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women (English)

1 reference

9 September 2017

Kristin K Snow

1

1 reference

9 September 2017

Jennifer Cote

2

1 reference

9 September 2017

Weining Yang

3

1 reference

9 September 2017

Nancy J Davis

4

1 reference

9 September 2017

Johanna M Seddon

5

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

American Journal of Ophthalmology

9 September 2017

1 reference

9 September 2017

134

1 reference

9 September 2017

842-848

1 reference

9 September 2017

6

1 reference

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Macular degeneration and early menopause: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the beaver dam eye study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Incidence of age-related cataract: the Beaver Dam Eye Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Lens opacities, demographic factors and nutritional supplements in the Barbados Eye Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Prevalence and risk factors of lens opacities in the elderly in Finland. A population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Cataracts and macular degeneration in older Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Oestrogens and macular holes: a postal questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Postmenopausal hormone therapy and mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Mechanisms of cardioprotection by estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

Oral contraception and eye disease: findings in two large cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901755-5

10.1016/S0002-9394(02)01755-5

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference